SCHEMBL8765016

SCHEMBL8765016

NS(=O)(=O)c1ccc(-c2[nH]nc(C(F)F)c2-c2ccccc2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 14/20 0.51
CA1 P00915 5/20 0.49
CA2 P00918 5/20 0.49
CA12 O43570 3/20 0.49
CA9 Q16790 3/20 0.49
MAPK1 P28482 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
MAOA P21397 1/20 0.43
MAOB P27338 1/20 0.43
LRRK2 Q5S007 1/20 0.43
PTGS1 P23219 2/20 0.43
MT-CO2 P00403 1/20 0.43
LMNA P02545 1/20 0.43
CA3 P07451 1/20 0.43
ADRB2 P07550 1/20 0.43
ADRB1 P08588 1/20 0.43
CYP3A4 P08684 1/20 0.43
ADORA3 P0DMS8 1/20 0.43
CHRM1 P11229 1/20 0.43
ADRA2B P18089 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8766312 0.87 PTGS2 (0.51) PTGS2PTGS1
SCHEMBL8764358 0.80 PTGS2 (0.52) PTGS2CA1CA2CA12CA9
SCHEMBL8953573 0.80 CA2 (0.44) PTGS2CA1CA2CA12CA9
SCHEMBL8953709 0.80 CA1 (0.47) PTGS2CA1CA2CA12CA9
SCHEMBL6182025 0.77 PTGS2 (0.52) PTGS2CA1CA2CA12CA9
SCHEMBL8606259 0.73 PTGS2 (0.52) PTGS2PTGS1
SCHEMBL8642614 0.73 PTGS2 (0.38) PTGS2PTGS1
SCHEMBL8765086 0.71 PTGS2 (0.54) PTGS2CA1CA2CA12CA9
SCHEMBL7090696 0.70 CA2 (0.66) PTGS2CA1CA2CA12CA9
SCHEMBL20931277 0.70 MAPK1 (0.44) MAPK1NPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0731794-B1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1997-08-06 EP disclosed
US-5639777-A 1,4,5-triphenyl pyrazolyl compounds for the treatment of inflammation and inflammation-related disorders G.D. SEARLE & CO. (US) 1997-06-17 US disclosed
EP-0731794-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS SEARLE & CO (US) 1996-09-18 EP disclosed
WO-1995015317-A1 1,4,5-TRIPHENYL PYRAZOLYL COMPOUNDS FOR THE TREATMENT OF INFLAMMATION AND INFLAMMATION-RELATED DISORDERS G.D. SEARLE & CO. (US) 1995-06-08 WO disclosed